MA50086A - Vésicules extracellulaires (ev) bactériennes - Google Patents
Vésicules extracellulaires (ev) bactériennesInfo
- Publication number
- MA50086A MA50086A MA050086A MA50086A MA50086A MA 50086 A MA50086 A MA 50086A MA 050086 A MA050086 A MA 050086A MA 50086 A MA50086 A MA 50086A MA 50086 A MA50086 A MA 50086A
- Authority
- MA
- Morocco
- Prior art keywords
- vesicles
- bacterial extracellular
- extracellular
- bacterial
- Prior art date
Links
- 230000001580 bacterial effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762556015P | 2017-09-08 | 2017-09-08 | |
US201862669151P | 2018-05-09 | 2018-05-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA50086A true MA50086A (fr) | 2020-07-15 |
Family
ID=63832482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA050086A MA50086A (fr) | 2017-09-08 | 2018-09-10 | Vésicules extracellulaires (ev) bactériennes |
Country Status (14)
Country | Link |
---|---|
US (2) | US11524037B2 (fr) |
EP (1) | EP3678693A1 (fr) |
JP (1) | JP7369690B2 (fr) |
KR (1) | KR20200053531A (fr) |
CN (1) | CN111148531A (fr) |
AR (1) | AR113011A1 (fr) |
AU (1) | AU2018330322A1 (fr) |
BR (1) | BR112020004264A2 (fr) |
CA (1) | CA3075268A1 (fr) |
CO (1) | CO2020004233A2 (fr) |
MA (1) | MA50086A (fr) |
MX (1) | MX2020002659A (fr) |
TW (1) | TWI814739B (fr) |
WO (1) | WO2019051380A1 (fr) |
Families Citing this family (128)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6774664B2 (ja) * | 2016-06-14 | 2020-10-28 | コリア リサーチ インスティチュート オブ バイオサイエンス アンド バイオテクノロジーKorea Research Institute Of Bioscience And Biotechnology | 退行性脳疾患の予防又は治療効果を有するアガトバキュラム属菌株及びその用途 |
AU2017327369A1 (en) | 2016-09-13 | 2019-05-02 | Allergan, Inc. | Stabilized non-protein Clostridial toxin compositions |
JP2020528898A (ja) | 2017-07-27 | 2020-10-01 | ローカス アイピー カンパニー、エルエルシー | 医薬品、サプリメント及び摂取物質のバイオアベイラビリティを増進する組成物 |
BR112020004264A2 (pt) | 2017-09-08 | 2020-10-06 | Evelo Biosciences, Inc. | vesículas extracelulares bacterianas |
EP3749340A1 (fr) * | 2018-02-06 | 2020-12-16 | Evelo Biosciences, Inc. | Compositions et méthodes pour traiter le cancer et des troubles immunitaires au moyen de bacteries veillonelles |
KR102122898B1 (ko) * | 2018-02-26 | 2020-06-15 | 주식회사 엠디헬스케어 | 블라우티아 속 세균 유래 나노소포 및 이의 용도 |
WO2019178490A1 (fr) | 2018-03-15 | 2019-09-19 | Evelo Biosciences, Inc. | Compositions et procédés pour traiter le cancer et l'inflammation utilisant klebsiella oxytoca |
WO2019178494A1 (fr) | 2018-03-15 | 2019-09-19 | Evelo Biosciences, Inc. | Compositions et méthodes de traitement du cancer et de l'inflammation à l'aide de tyzzerella nexilis |
WO2019178487A2 (fr) | 2018-03-15 | 2019-09-19 | Evelo Biosciences, Inc. | Compositions et méthodes de traitement d'une maladie à l'aide de klebsiella quasipneumoniae subsp. similipneumoniae |
MA52011A (fr) | 2018-03-16 | 2021-01-20 | Zoetis Services Llc | Vaccins peptidiques contre l'interleukine-31 |
WO2019232122A1 (fr) * | 2018-05-30 | 2019-12-05 | University Of Florida Research Foundation, Inc. | Efecteur bactérien mécaniste destiné à empêcher l'apoptose de cellules bêta humaines |
CN108949699B (zh) * | 2018-08-03 | 2020-09-04 | 江南大学 | 一种分泌美洛昔康单克隆抗体的杂交瘤细胞株及其应用 |
AU2019351019A1 (en) | 2018-09-27 | 2021-04-22 | Research Development Foundation | Methods and probiotic compositions for the treatment of bone disorders |
CN109207425A (zh) * | 2018-09-29 | 2019-01-15 | 中国医科大学附属口腔医院 | 牙龈卟啉单胞菌诱导巨噬细胞外泌体rna表达研究方法 |
WO2020122448A1 (fr) * | 2018-12-10 | 2020-06-18 | 주식회사 엠디헬스케어 | Nanovésicule dérivée de la bactérie weissella et son utilisation |
JP7441534B2 (ja) * | 2019-01-09 | 2024-03-01 | エムディー ヘルスケア インコーポレイテッド | ロドコッカス属細菌由来ナノ小胞およびその用途 |
WO2020145661A1 (fr) * | 2019-01-09 | 2020-07-16 | 주식회사 엠디헬스케어 | Nanovésicules dérivées de bactéries du genre propionibacterium et leur utilisation |
CN109762762A (zh) * | 2019-01-11 | 2019-05-17 | 江苏大学 | 一种脂肽的高产菌株及其制备方法和用途 |
KR102285335B1 (ko) * | 2019-02-14 | 2021-08-04 | 주식회사 엠디헬스케어 | 로치아 속 세균 유래 나노소포 및 이의 용도 |
CA3130776A1 (fr) * | 2019-02-22 | 2020-08-27 | Evelo Biosciences, Inc. | Preparations de membrane bacterienne |
CN110195028B (zh) * | 2019-03-08 | 2022-03-01 | 大连理工大学 | 一种堆肥低温复合发酵菌剂的制备方法及应用 |
US20220218811A1 (en) * | 2019-04-17 | 2022-07-14 | Codiak Biosciences, Inc. | Methods of treating tuberculosis |
CN111991427A (zh) * | 2019-05-07 | 2020-11-27 | 瑞微(深圳)生物科技有限公司 | 肠道细菌在制备用于促进TCR γδ+T细胞增殖的药物中的应用 |
CN110317744B (zh) * | 2019-05-08 | 2021-11-05 | 安徽农业大学 | 一种生产蓝紫色素的马赛菌及其生产蓝紫色素的方法 |
WO2020252144A1 (fr) * | 2019-06-11 | 2020-12-17 | Evelo Biosciences, Inc. | Vésicules extracellulaires microbiennes sécrétées |
EP3987046A4 (fr) | 2019-06-20 | 2023-08-02 | Locus IP Company, LLC | Co-culture d'une myxobacterium et d'acinetobacter pour une production améliorée d'émulsan |
WO2021016081A1 (fr) * | 2019-07-19 | 2021-01-28 | Finch Therapeutics Holdings Llc. | Méthodes et produits destinés au traitement de troubles gastro-intestinaux |
EP4010077A1 (fr) * | 2019-08-05 | 2022-06-15 | Evelo Biosciences, Inc. | Compositions et procédés de traitement du psoriasis et de la dermatite atopique faisant appel à prevotella histicola |
CN110577910B (zh) * | 2019-09-17 | 2022-02-01 | 南京农业大学 | 一种侧孢短芽孢杆菌、抗菌脂肽及其在农业与食品上的应用 |
EP4031152A4 (fr) * | 2019-09-18 | 2023-10-04 | Research Development Foundation | Composés et compositions probiotiques pour le traitement de maladies et de troubles métaboliques |
CN110628862A (zh) * | 2019-09-24 | 2019-12-31 | 哈尔滨工业大学 | 一种废水梯级能源回收的自聚集颗粒污泥构建方法 |
CN110982729A (zh) * | 2019-10-23 | 2020-04-10 | 江苏省中国科学院植物研究所 | 一种降解木材加工副产物杨树皮纤维素的复合菌剂 |
CN110804621A (zh) * | 2019-10-31 | 2020-02-18 | 郑州大学 | 一种内源性高表达miRNA的大肠杆菌胞外囊泡的制备方法 |
WO2021138571A1 (fr) * | 2019-12-31 | 2021-07-08 | Assembly Biosciences, Inc. | Compositions comprenant des espèces bactériennes et procédés associés |
WO2021137494A1 (fr) * | 2020-01-02 | 2021-07-08 | 삼육대학교산학협력단 | Composition pour la prévention ou le traitement du diabète comprenant une souche de butyricimonas sp. en tant que principe actif |
WO2021142279A1 (fr) * | 2020-01-10 | 2021-07-15 | Evelo Biosciences, Inc. | Compositions et procédés de traitement à l'aide de veillonella parvula |
WO2021146523A1 (fr) * | 2020-01-17 | 2021-07-22 | Evelo Biosciences, Inc. | Formes posologiques solides à profils de désintégration améliorés |
US20240009256A1 (en) * | 2020-02-04 | 2024-01-11 | University Of Louisville Research Foundation, Inc. | Use of probiotic bacterium-derived extracellular micro- and/or nanoparticles for the treatment of disease |
CN111052997B (zh) * | 2020-02-25 | 2022-07-01 | 青岛农业大学 | 一种提高草莓连作障碍抗性生物刺激素的制备及应用方法 |
US11744866B2 (en) | 2020-03-18 | 2023-09-05 | Sabine Hazan | Methods of preventing and treating COVID-19 infection with probiotics |
US11253534B2 (en) | 2020-03-23 | 2022-02-22 | Sabine Hazan | Method of preventing COVID-19 infection |
US11278520B2 (en) | 2020-03-31 | 2022-03-22 | Sabine Hazan | Method of preventing COVID-19 infection |
CN116033835A (zh) * | 2020-04-03 | 2023-04-28 | 杜邦营养生物科学有限公司 | 用于改善代谢健康的包含细菌菌株的组合物 |
WO2021205444A1 (fr) * | 2020-04-06 | 2021-10-14 | Yeda Research And Development Co. Ltd. | Méthodes de diagnostic du cancer et de prédiction de la réactivité à une thérapie |
KR102273232B1 (ko) * | 2020-05-08 | 2021-07-06 | 코스맥스 주식회사 | 마이크로코커스 리래 균주 및 그의 피부 상태 개선 용도 |
KR102273234B1 (ko) * | 2020-05-08 | 2021-07-06 | 코스맥스 주식회사 | 코쿠리아 바리안스 균주 및 그의 피부 상태 개선 용도 |
CN111560330B (zh) * | 2020-05-12 | 2022-04-26 | 天津科技大学 | 一种具有免疫调节、抗炎和抗宫颈癌作用的干酪乳杆菌及应用 |
GB202007452D0 (en) | 2020-05-19 | 2020-07-01 | Microbiotica Ltd | Threrapeutic bacterial composition |
WO2021242056A1 (fr) * | 2020-05-28 | 2021-12-02 | 주식회사 바이오뱅크힐링 | Souche de l'espèce bifidobacterium et vésicule extracellulaire dérivée de cette dernière, et leurs utilisations anti-inflammatoires et antibactériennes |
US20230302061A1 (en) * | 2020-06-11 | 2023-09-28 | Evelo Biosciences, Inc. | Compositions and methods for treating diseases and disorders using fournierella massiliensis |
WO2021252877A1 (fr) * | 2020-06-11 | 2021-12-16 | Evelo Biosciences, Inc. | Compositions et méthodes de traitement de maladies et de troubles à l'aide de vésicules extracellulaires microbiennes d'oscillospiraceae |
WO2021252861A1 (fr) * | 2020-06-11 | 2021-12-16 | Evelo Biosciences, Inc. | Compositions et méthodes de traitement de maladies et de troubles à l'aide de mégasphaera sp. |
US20230218683A1 (en) * | 2020-06-11 | 2023-07-13 | Evelo Biosciences, Inc. | Compositions and methods for treating diseases and disorders using harryflintia acetispora |
JP7385301B2 (ja) * | 2020-06-16 | 2023-11-22 | エムディー ヘルスケア インコーポレイテッド | ラクトバチルス・パラカゼイ由来小胞を含む神経疾患又は精神疾患の予防又は治療用組成物 |
CN116056723A (zh) * | 2020-06-22 | 2023-05-02 | 罗塞塔外排体株式会社 | 增强细菌胞外囊泡的癌症治疗效果的方法和组合物 |
KR102469138B1 (ko) * | 2020-07-07 | 2022-11-22 | 주식회사 엘제이바이오 | 파라클로스트리디움 벤조에리티쿰 ks3 균주를 포함하는 가축 사체 분해 촉진용 미생물 제제 |
CN111743922B (zh) * | 2020-07-14 | 2022-03-29 | 华熙生物科技股份有限公司 | 一种提高益生菌在鼻腔中的定植和活性的组合物及在鼻腔护理中的应用 |
JP2023534834A (ja) * | 2020-07-21 | 2023-08-14 | エヴェロ バイオサイエンシズ,インコーポレーテッド | 神経炎症性疾患の経口療法薬としてのベイロネラ・パルブラ(Veillonella parvula)株 |
EP4188399A2 (fr) * | 2020-08-03 | 2023-06-07 | Universiteit Gent | Compositions bactériennes présentant une activité anti-inflammatoire |
CN111876359A (zh) * | 2020-08-04 | 2020-11-03 | 榆林沙漠王生物科技有限公司 | 一种用于蔬菜残体资源化处理的复配菌剂及其制备方法及应用 |
WO2022035269A1 (fr) * | 2020-08-14 | 2022-02-17 | 주식회사 고바이오랩 | Souche de faecalibacterium prausnitzii et ses utilisations |
CN112094820B (zh) * | 2020-09-17 | 2021-12-07 | 扬州大学 | 霍氏肠杆菌噬菌体yzu.p.a-5及其应用 |
JP2023543416A (ja) * | 2020-09-18 | 2023-10-16 | エヴェロ バイオサイエンシズ,インコーポレーテッド | 細菌の固形剤形 |
TW202227111A (zh) * | 2020-09-21 | 2022-07-16 | 美商艾弗洛生物科技股份有限公司 | 具有改善的崩散譜之固體劑型 |
CN112094328A (zh) * | 2020-09-21 | 2020-12-18 | 华南农业大学 | 一种空肠弯曲杆菌外膜囊泡的提取及纯化方法 |
CN112094778B (zh) * | 2020-09-24 | 2022-06-24 | 千禾味业食品股份有限公司 | 一种魏斯氏菌las1、制备方法及其应用 |
AR123960A1 (es) * | 2020-10-29 | 2023-01-25 | Evelo Biosciences Inc | Composiciones que comprenden componentes de espirulina |
CN114438235A (zh) * | 2020-11-04 | 2022-05-06 | 深圳市南山区疾病预防控制中心 | 一种同时检测嗜低温弓形杆菌及斯氏弓形杆菌的引物探针组件、试剂盒及其应用 |
US20240033303A1 (en) * | 2020-12-08 | 2024-02-01 | Md Healthcare Inc. | Composition for preventing or treating neurological diseases or psychiatric diseases comprising vesicles derived from sphingomonas bacteria |
KR102269962B1 (ko) | 2020-12-11 | 2021-06-28 | 주식회사 바이오뱅크힐링 | 유박테리움 리모숨 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
FR3118060A1 (fr) * | 2020-12-18 | 2022-06-24 | Université de Bourgogne | Utilisation anti-biofilm de vesicules membranaires extracellulaires |
WO2022139532A1 (fr) * | 2020-12-23 | 2022-06-30 | 주식회사 리스큐어바이오사이언시스 | Composition pour améliorer, prévenir ou traiter une stéatose hépatique, comprenant une vésicule extracellulaire dérivée de weissella hellenica en tant que principe actif |
WO2022139530A1 (fr) * | 2020-12-23 | 2022-06-30 | 주식회사 리스큐어바이오사이언시스 | Composition destinée à réduire, prévenir ou traiter des maladies auto-immunes comprenant des vésicules extracellulaires dérivées de lactobacillus sakei en tant que principe actif |
WO2022139531A1 (fr) * | 2020-12-23 | 2022-06-30 | 주식회사 리스큐어바이오사이언시스 | Composition pour améliorer, prévenir ou traiter une stéatose hépatique comprenant des vésicules extracellulaires dérivées de leuconostoc citreum en tant que principe actif |
WO2022145900A1 (fr) * | 2020-12-28 | 2022-07-07 | 주식회사 리스큐어바이오사이언시스 | Composition pharmaceutique pour la prévention ou le traitement du cancer, comprenant en tant que principe actif des nanovésicules issues d'une souche de weissella cibaria |
KR102651196B1 (ko) * | 2020-12-28 | 2024-03-27 | 주식회사 엠디헬스케어 | 마이크로코커스 루테우스 유래 세포외 소포를 포함하는 안질환 예방 또는 치료용 조성물 |
EP4268836A1 (fr) * | 2020-12-28 | 2023-11-01 | MD Healthcare Inc. | Composition pour la prévention ou le traitement de maladies neuro-développementales, neurologiques ou psychiatriques, comprenant des vésicules extracellulaires dérivées de micrococcus luteus |
WO2022145680A1 (fr) * | 2020-12-28 | 2022-07-07 | 주식회사 엠디헬스케어 | Composition pour la prévention ou le traitement d'une maladie pulmonaire neutrophile comprenant des vésicules extracellulaires dérivées de micrococcus luteus |
WO2022145901A1 (fr) * | 2020-12-28 | 2022-07-07 | 주식회사 리스큐어바이오사이언시스 | Composition pharmaceutique pour la prévention ou le traitement du cancer comprenant des nanovésicules dérivées d'une souche de lactobacillus fermentum en tant que principe actif |
WO2022145902A1 (fr) * | 2020-12-28 | 2022-07-07 | 주식회사 리스큐어바이오사이언시스 | Composition pharmaceutique destinée à la prévention ou au traitement du cancer, comprenant des nanovésicules dérivées d'une souche de lactobacillus sakei en tant qu'ingrédient actif |
WO2022154149A1 (fr) * | 2021-01-14 | 2022-07-21 | (주)엑솔런스 | Composition vaccinale utilisant une vésicule extracellulaire |
EP4285916A1 (fr) | 2021-02-01 | 2023-12-06 | MD Healthcare Inc. | Composition comprenant des vésicules dérivées de lactobacillus paracasei pour prévenir, traiter ou soulager des maladies infectieuses virales ou des maladies respiratoires |
WO2022177412A1 (fr) * | 2021-02-22 | 2022-08-25 | 주식회사 리스큐어바이오사이언시스 | Composition pharmaceutique pour la prévention ou le traitement du cancer comprenant en tant que principe actif des nanovésicules issues d'une souche de weissella cibaria |
EP4297762A1 (fr) * | 2021-02-26 | 2024-01-03 | Evelo Biosciences, Inc. | Compositions et procédés pour réduire l'expression de cytokine |
IL305830A (en) * | 2021-03-12 | 2023-11-01 | Marvelbiome Inc | Methods and uses of microbiome compositions, components or metabolites for the treatment of eye disorders |
US20240180833A1 (en) * | 2021-04-02 | 2024-06-06 | Md Healthcare Inc. | Nanovesicles derived from bacteria of the genus paracoccus and use thereof |
CN113186172A (zh) * | 2021-04-06 | 2021-07-30 | 天津农学院 | 共表达Apoptin与MEL基因的重组腺病毒及构建方法和应用 |
WO2022221183A1 (fr) * | 2021-04-12 | 2022-10-20 | Evelo Biosciences, Inc. | Préparations de vésicules extracellulaires de fournierella |
CN113025534B (zh) * | 2021-04-26 | 2022-05-27 | 佛山市南海东方澳龙制药有限公司 | 一株具有较强抑菌作用的新种芽孢杆菌x901株及其应用 |
CN115305211A (zh) * | 2021-05-07 | 2022-11-08 | 葡萄王生技股份有限公司 | 益生菌胞外泌体及其用途 |
CN113186134B (zh) * | 2021-05-17 | 2022-11-01 | 中国科学院水生生物研究所 | 一种蓝藻气囊提取方法及其应用 |
CN113122483A (zh) * | 2021-05-31 | 2021-07-16 | 哈尔滨工业大学 | 一种玉米秸秆好氧堆肥的快速产热菌剂及其应用 |
JP7396737B2 (ja) * | 2021-06-03 | 2023-12-12 | エムディー ヘルスケア インコーポレイテッド | ラクトバチルス・パラカゼイ由来細胞外小胞を含む眼疾患の予防または治療用組成物 |
US20240252560A1 (en) * | 2021-06-03 | 2024-08-01 | Md Healthcare Inc. | Lactobacillus rhamnosus-derived vesicle and uses thereof |
JP2024520696A (ja) * | 2021-06-03 | 2024-05-24 | エムディー ヘルスケア インコーポレイテッド | ラクトバチルス菌由来細胞外小胞及びその用途 |
KR102661178B1 (ko) * | 2021-06-03 | 2024-04-29 | 주식회사 엠디헬스케어 | 락토바실러스 파라카세이 유래 세포외소포를 포함하는 안질환 예방 또는 치료용 조성물 |
JP2024520165A (ja) * | 2021-06-07 | 2024-05-21 | エムディー ヘルスケア インコーポレイテッド | ロイコノストック細菌由来小胞を含む炎症疾患あるいはがんの予防または治療用組成物 |
JP2024527078A (ja) * | 2021-07-28 | 2024-07-19 | ザ テキサス エーアンドエム ユニヴァーシティ システム | ブルセラ属株を含むワクチン組成物及びそれらの方法 |
KR102390775B1 (ko) * | 2021-09-06 | 2022-05-04 | 한국식품연구원 | 류코노스톡 슈도메센테로이데스 WiKim0138 균주를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물 |
KR102390755B1 (ko) * | 2021-09-06 | 2022-04-28 | 한국식품연구원 | 웨이셀라 파라메센테로이데스 WiKim0137 균주를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물 |
KR102558084B1 (ko) * | 2021-09-14 | 2023-07-21 | 코스맥스 주식회사 | 두피 마이크로바이옴 콤플렉스 및 그의 모발 또는 두피 상태 개선 용도 |
CN113999789B (zh) * | 2021-09-30 | 2022-11-15 | 沈阳农业大学 | 一株产鲜味肽的嗜盐四联球菌及应用 |
WO2023062422A1 (fr) * | 2021-10-11 | 2023-04-20 | Vastu Vihar Biotech Private Limited | Composition anti-inflammatoire et son procédé d'obtention |
KR102411242B1 (ko) * | 2021-10-18 | 2022-06-22 | 큐티스바이오 주식회사 | 클렙시엘라 아에로제네스의 피부 상태 개선 용도 |
KR102411241B1 (ko) * | 2021-10-18 | 2022-06-22 | 큐티스바이오 주식회사 | 코리네박테리움 상귀니스의 피부 상태 개선 용도 |
KR20230056619A (ko) * | 2021-10-20 | 2023-04-27 | 주식회사 고바이오랩 | 항암 활성을 갖는 베일로넬라 파르불라 균주를 이용한 암의 완화, 예방 또는 치료용 조성물 |
WO2023075458A1 (fr) * | 2021-10-27 | 2023-05-04 | 주식회사 바이오뱅크힐링 | Nouvelle souche bactérienne, vésicules dérivées de celle-ci, et utilisation anti-inflammatoire et anti-bactérienne associées |
CN114085792B (zh) * | 2021-11-17 | 2023-03-24 | 哈尔滨医科大学 | 一种用于防治结肠癌的副干酪乳杆菌及其应用 |
WO2023092141A2 (fr) * | 2021-11-22 | 2023-05-25 | Dupont Nutrition Biosciences Aps | Compositions pour santé métabolique |
CA3238764A1 (fr) | 2021-11-23 | 2023-06-01 | Siddharth Patel | Composition lipidique derivee de bacteries et son utilisation |
WO2023114296A2 (fr) * | 2021-12-14 | 2023-06-22 | Evelo Biosciences, Inc. | Préparations de vésicules extracellulaires |
WO2023114300A1 (fr) * | 2021-12-14 | 2023-06-22 | Evelo Biosciences, Inc. | Préparations de vésicules extracellulaires de bactéries fournierella massiliensis |
CN114369673B (zh) * | 2022-01-06 | 2023-07-14 | 同济大学 | 结直肠腺瘤生物标志物、试剂盒及生物标志物的筛选方法 |
AU2023210125A1 (en) * | 2022-01-20 | 2024-08-08 | Korea Institute Of Science And Technology | Composition for prevention, amelioration or treatment of non-alcoholic fatty liver disease, comprising extracellular vesicles derived from roseburia spp. or bifidobacterium spp. |
CN114807032B (zh) * | 2022-05-20 | 2023-09-12 | 南京大学 | 地塞米松诱导中性粒细胞产生的细胞外囊泡在制备治疗消炎药物中的应用 |
KR102509869B1 (ko) * | 2022-07-14 | 2023-03-14 | 주식회사 엔테로바이옴 | 아커만시아를 포함하는 탈모 예방 또는 치료용 약학적 조성물 |
KR102620190B1 (ko) * | 2022-08-31 | 2024-01-04 | 주식회사 바이오뱅크힐링 | 아가토박터 렉탈리스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
KR102620189B1 (ko) * | 2022-08-31 | 2024-01-04 | 주식회사 바이오뱅크힐링 | 블라우티아 브룩킹시 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
KR102626400B1 (ko) * | 2022-08-31 | 2024-01-19 | 주식회사 바이오뱅크힐링 | 도레아 론기카테나 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
WO2024049207A1 (fr) * | 2022-08-31 | 2024-03-07 | 주식회사 바이오뱅크힐링 | Nouvelle souche et vésicules qui en sont issues, et leurs utilisations anti-inflammatoires et antibactériennes |
CN116509900B (zh) * | 2022-12-01 | 2023-11-10 | 佛山科学技术学院 | 益生菌或其细胞外囊泡在制备防治胃溃疡产品中的应用 |
CN116656583B (zh) * | 2023-01-13 | 2024-06-18 | 南昌大学 | 靶向肿瘤的幽门螺杆菌突变株及抗胃癌外膜囊泡组合物 |
WO2024177349A1 (fr) * | 2023-02-21 | 2024-08-29 | 주식회사 엠디헬스케어 | Composition pour la prévention ou le traitement d'une maladie métabolique, d'une maladie hépatique ou d'une maladie musculaire comprenant des vésicules dérivées de bactéries leuconostoc sp. |
CN116622548B (zh) * | 2023-03-31 | 2024-02-09 | 吉林农业大学 | 一株能够预防和或治疗牙周炎的嵴链球菌及其应用 |
CN116747245B (zh) * | 2023-06-14 | 2024-06-21 | 辽宁越秀辉山营养科技有限公司 | 动物双歧杆菌乳亚种bx-245在抑菌和/或生产功能活性物质中的应用 |
CN117180317B (zh) * | 2023-11-02 | 2024-01-26 | 深圳市第二人民医院(深圳市转化医学研究院) | 詹氏乳杆菌来源纳米囊泡在制备防治卵巢早衰治疗药物中的应用 |
CN117402794B (zh) * | 2023-12-12 | 2024-02-27 | 四川厌氧生物科技有限责任公司 | 一种加氏乳杆菌及其应用 |
CN118006515B (zh) * | 2024-04-08 | 2024-06-18 | 中国农业大学 | 一株乳酸乳球菌及其在制备治疗牛乳腺炎的药物中的应用 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5322784A (en) | 1991-06-05 | 1994-06-21 | The Board Of Trustees Of The University Of Illinois, Urbana-Champaign, Illinois | Method and materials for introducing DNA into Prevotella ruminicola |
EP1261355B1 (fr) | 2000-03-01 | 2004-12-01 | Société des Produits Nestlé S.A. | Formulation de carbohydrate (adjuvant prebiotique) destine a augmenter une reponse immune |
AU2001280883A1 (en) * | 2000-07-27 | 2002-02-13 | The Children's Hospital & Research Center At Oakland | Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
GB0130123D0 (en) * | 2001-12-17 | 2002-02-06 | Microbiological Res Agency | Outer membrane vesicle vaccine and its preparation |
JPWO2004087210A1 (ja) | 2003-03-31 | 2006-06-29 | 麒麟麦酒株式会社 | 抗cd52抗体による調節性t細胞分化誘導・増殖方法およびそのための医薬組成物 |
CN102480932B (zh) * | 2009-09-01 | 2015-01-14 | 阿昂梅迪克斯公司 | 源于肠道共生细菌的细胞外小泡及利用其的疫苗、备选药物筛选方法 |
GB0917003D0 (en) | 2009-09-28 | 2009-11-11 | Novartis Vaccines Inst For Global Health Srl | Purification of bacterial vesicles |
WO2011053653A2 (fr) * | 2009-10-30 | 2011-05-05 | Mayo Foundation For Medical Education And Research | Préparations à base de prevotella histicola et traitement d'états auto-immuns |
EP2589391B1 (fr) | 2010-07-01 | 2018-11-14 | Rosetta Exosome Co., Ltd. | Microvésicules de cellules bactériennes pour application dans le traitement du cancer |
WO2014152484A1 (fr) * | 2013-03-14 | 2014-09-25 | Regents Of The University Of Minnesota | Microbiote fécal lyophilisé à utiliser dans la transplantation microbienne fécale |
US9968638B2 (en) * | 2011-03-09 | 2018-05-15 | Regents Of The University Of Minnesota | Compositions and methods for transplantation of colon microbiota |
TWI573590B (zh) | 2011-09-20 | 2017-03-11 | 雷希爾生藥有限公司 | 治療自體免疫疾病之組成物及方法 |
JP6133894B2 (ja) | 2011-12-28 | 2017-05-24 | ガレクティン・セラピューティクス・インコーポレイテッドGalectin Therapeutics, Inc. | ヒト疾患処置用の新規糖薬剤の組成物 |
PL3016527T3 (pl) | 2013-06-03 | 2019-02-28 | Proprev Ab | Leczenie otyłości, zespołu metabolicznego, cukrzycy typu 2, chorób sercowo-naczyniowych, otępienia, choroby alzheimera i zapalnej choroby jelit poprzez zastosowanie co najmniej jednego szczepu bakteryjnego prevotella |
KR101740893B1 (ko) | 2014-05-20 | 2017-06-13 | 주식회사 엠디헬스케어 | Akkermansia muciniphila 균에서 유래하는 세포밖 소포를 유효성분으로 함유하는 대사질환의 치료 또는 예방용 조성물 |
MA41020A (fr) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
EP3227434A4 (fr) | 2014-12-03 | 2018-07-11 | Capricor, Inc. | Procédés de production d'exosomes dans des conditions de culture à teneur en oxygène réduite |
EP3268018A4 (fr) * | 2015-03-12 | 2018-10-31 | The University of British Columbia | Compositions bactériennes et leurs procédés d'utilisation |
US10722543B2 (en) | 2016-01-28 | 2020-07-28 | Oxyrase, Inc. | Methods for inhibiting tumor growth using anaerobe microorganisms |
BR112020004264A2 (pt) | 2017-09-08 | 2020-10-06 | Evelo Biosciences, Inc. | vesículas extracelulares bacterianas |
-
2018
- 2018-09-10 BR BR112020004264-1A patent/BR112020004264A2/pt unknown
- 2018-09-10 MX MX2020002659A patent/MX2020002659A/es unknown
- 2018-09-10 CN CN201880058100.6A patent/CN111148531A/zh active Pending
- 2018-09-10 US US16/645,019 patent/US11524037B2/en active Active
- 2018-09-10 WO PCT/US2018/050211 patent/WO2019051380A1/fr unknown
- 2018-09-10 JP JP2020513524A patent/JP7369690B2/ja active Active
- 2018-09-10 KR KR1020207010043A patent/KR20200053531A/ko not_active Application Discontinuation
- 2018-09-10 AR ARP180102564A patent/AR113011A1/es unknown
- 2018-09-10 AU AU2018330322A patent/AU2018330322A1/en not_active Abandoned
- 2018-09-10 CA CA3075268A patent/CA3075268A1/fr active Pending
- 2018-09-10 MA MA050086A patent/MA50086A/fr unknown
- 2018-09-10 TW TW107131777A patent/TWI814739B/zh active
- 2018-09-10 EP EP18785472.4A patent/EP3678693A1/fr active Pending
-
2020
- 2020-04-06 CO CONC2020/0004233A patent/CO2020004233A2/es unknown
-
2022
- 2022-12-02 US US18/074,122 patent/US20230210913A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20200053531A (ko) | 2020-05-18 |
CO2020004233A2 (es) | 2020-04-24 |
AU2018330322A1 (en) | 2020-03-19 |
TW201919673A (zh) | 2019-06-01 |
US20200254028A1 (en) | 2020-08-13 |
TWI814739B (zh) | 2023-09-11 |
EP3678693A1 (fr) | 2020-07-15 |
JP2020533290A (ja) | 2020-11-19 |
AR113011A1 (es) | 2020-01-15 |
CA3075268A1 (fr) | 2019-03-14 |
JP7369690B2 (ja) | 2023-10-26 |
US11524037B2 (en) | 2022-12-13 |
US20230210913A1 (en) | 2023-07-06 |
WO2019051380A1 (fr) | 2019-03-14 |
BR112020004264A2 (pt) | 2020-10-06 |
MX2020002659A (es) | 2020-09-09 |
CN111148531A (zh) | 2020-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA50086A (fr) | Vésicules extracellulaires (ev) bactériennes | |
IL277344A (en) | Extracellular vesicles containing agonist-STING | |
MA50087A (fr) | Vésicules extracellulaires provenant de prevotella | |
DK3145949T3 (da) | Lentivirale vektorer | |
DK3013070T3 (da) | Høresystem | |
SG11201610843SA (en) | 360 degree privacy film | |
BR112017000446A2 (pt) | arranjos de estação de acionamento | |
IL274124A (en) | Protein engineered extracellular vesicles | |
DK3006079T3 (da) | Høresystem | |
BR112017001200A2 (pt) | “curativo laminado de espuma” | |
EP3238468A4 (fr) | Services de localisation | |
DK3001700T3 (da) | Positioneret høresystem | |
DK3385377T3 (da) | Bakteriemannanaser | |
DK3272129T3 (da) | Kommunikationssystem | |
BR112016018442A2 (pt) | agentes antibacterianos | |
GB2555997B (en) | Downhole acoustic source localization | |
SG11202003499YA (en) | Immunomodulatory composition comprising lactobacillus-derived extracellular vesicles | |
EP3179740A4 (fr) | Excitateur | |
FR3040689B1 (fr) | Drone aeroterrestre de livraison | |
DK3035303T3 (da) | Returautomat | |
ES1202511Y (es) | Maquina satinadora-cepilladora | |
DE112015002970A5 (de) | Netzwerksystem | |
UA37267S (uk) | Домофон | |
ES1202661Y (es) | Maquina satinadora-cepilladora | |
IT201700054846A1 (it) | Drone |